chloramphenicol sodium succinate · Parkedale · NDA 050143, 050153, 050155, 050156, 050183, 050205
Chloromycetin
Earliest generic entry, as listed
Open now
No marketed reference-listed strength; date taken from all listed strengths.
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 6
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 050143 · 001 · discontinued | for solution, ophthalmic | 25MG/VIAL | open |
| 050153 · 001 · discontinued | injectable, injection | 250MG/ML | open |
| 050155 · 001 · RLD · discontinued | injectable, injection | EQ 1GM BASE/VIAL | open |
| 050156 · 001 · discontinued | ointment, ophthalmic | 1% | open |
| 050183 · 001 · discontinued | cream, topical | 1% | open |
| 050205 · 001 · discontinued | solution/drops, otic | 0.5% | open |